Teza Capital Management’s Zimmer Biomet ZBH Stock Holding History

Teza Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,714	Closed	-$729K	–	772
2024 Q2	$729K	Buy	+6,714	New	+$791K	0.09%	299
2023 Q2	–	Sell	-10,521	Closed	-$1.36M	–	748
2023 Q1	$1.36M	Buy	+10,521	New	+$1.32M	0.29%	102
2022 Q4	–	Sell	-12,471	Closed	-$1.3M	–	745
2022 Q3	$1.3M	Buy	12,471 +8,830	+243%	+$969K	0.27%	101
2022 Q2	$383K	Buy	+3,641	New	+$432K	0.15%	257
2020 Q3	–	Sell	-20,135	Closed	-$2.33M	–	641
2020 Q2	$2.33M	Buy	+20,135	New	+$2.32M	0.52%	38
2020 Q1	–	Sell	-3,146	Closed	-$457K	–	525
2019 Q4	$457K	Sell	3,146 -3,458	-52%	-$477K	0.13%	297
2019 Q3	$880K	Sell	6,604 -1,858	-22%	-$240K	0.22%	146
2019 Q2	$967K	Buy	+8,462	New	+$991K	0.57%	41
2019 Q1	–	Sell	-5,973	Closed	-$601K	–	443
2018 Q4	$601K	Buy	+5,973	New	+$672K	0.23%	161

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Teza Capital Management's ZBH Position: Q3 2024 in Review

Teza Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 6,714 shares — an estimated $729K sold.

Teza Capital Management first reported a position in ZBH in Q4 2018 and held it in 9 quarters. The position peaked at $2.33M in Q2 2020. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

Teza Capital Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
Teza Capital Management sold 6,714 Zimmer Biomet shares in Q3 2024, an estimated $729K.
Teza Capital Management first reported a position in Zimmer Biomet in Q4 2018 and held it in 9 quarters.
Teza Capital Management's Zimmer Biomet position peaked at $2.33M in Q2 2020.
981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Teza Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.